Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Estrogens
Drug ID BADD_D00831
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID Not Available
KEGG ID Not Available
MeSH ID D004967
PubChem ID 23676225
TTD Drug ID Not Available
NDC Product Code Not Available
UNII 7XY8FW3E68
Synonyms Estrogens | Estrogenic Compounds | Compounds, Estrogenic | Estrogenic Agents | Agents, Estrogenic | Estrogen | Estrogen Receptor Agonists | Agonists, Estrogen Receptor | Receptor Agonists, Estrogen | Estrogen Effect | Estrogenic Effect | Estrogenic Effects | Effects, Estrogenic | Estrogen Effects | Effects, Estrogen
Chemical Information
Molecular Formula C18H19NaO5S
CAS Registry Number 12126-59-9
SMILES CC12CCC3C(=CCC4=C3C=CC(=C4)OS(=O)(=O)[O-])C1CCC2=O.[Na+]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Weight decreased13.15.01.005--
Weight increased13.15.01.006--
Deep vein thrombosis24.01.02.003--Not Available
Affect lability19.04.01.001--Not Available
Breast disorder21.05.04.004--Not Available
Libido disorder21.03.02.006; 19.08.03.004--Not Available
Hyperlipidaemia14.08.03.001--
Retinal vascular thrombosis24.01.07.001; 06.10.01.004--Not Available
Candida infection11.03.03.021--
Abnormal uterine bleeding21.01.01.013--Not Available
Intermenstrual bleeding21.01.01.015--Not Available
Superficial vein thrombosis24.01.02.016--Not Available
The 4th Page    First    Pre   4    Total 4 Pages